Login
Home
Charts
Search
Watchlist
Products

Tanfac Industries Ltd

TANFACIND·BSE
3,425.85-0.06%Wed, 23 Sept '26

Tanfac Industries Ltd

TANFACIND
BSE
3,425.85
-0.06%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7,411Cr
Close
Close Price
3,425.85
Industry
Industry
Chemicals - Inorganic
PE
Price To Earnings
101.12
PS
Price To Sales
10.26
Revenue
Revenue
722Cr
Rev Gr TTM
Revenue Growth TTM
13.27%
PAT Gr TTM
PAT Growth TTM
-29.69%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
818810395112178172176169173193187
Growth YoY
Revenue Growth YoY%
5.1-11.1-11.0-10.237.0103.067.384.651.3-2.712.36.3
Expenses
ExpensesCr
6673868084128136147142147163159
Operating Profit
Operating ProfitCr
161516162750362927263029
OPM
OPM%
19.216.615.916.424.428.220.816.515.914.915.715.3
Other Income
Other IncomeCr
212110111011
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
222223444555
PBT
PBTCr
151416152646312523202524
Tax
TaxCr
4444712855577
PAT
PATCr
111013111935231917161817
Growth YoY
PAT Growth YoY%
33.5-38.0-43.4-38.669.8245.279.571.4-11.0-55.3-20.7-12.9
NPM
NPM%
14.011.512.311.817.319.513.211.010.29.09.39.0
EPS
EPS
5.75.06.35.79.717.411.49.78.67.89.08.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
818810395112178172176169173193187
Growth YoY
Revenue Growth YoY%
5.1-11.1-11.0-10.237.0103.067.384.651.3-2.712.36.3
Expenses
ExpensesCr
6673868084128136147142147163159
Operating Profit
Operating ProfitCr
161516162750362927263029
OPM
OPM%
19.216.615.916.424.428.220.816.515.914.915.715.3
Other Income
Other IncomeCr
212110111011
Interest Expense
Interest ExpenseCr
000001111111
Depreciation
DepreciationCr
222223444555
PBT
PBTCr
151416152646312523202524
Tax
TaxCr
4444712855577
PAT
PATCr
111013111935231917161817
Growth YoY
PAT Growth YoY%
33.5-38.0-43.4-38.669.8245.279.571.4-11.0-55.3-20.7-12.9
NPM
NPM%
14.011.512.311.817.319.513.211.010.29.09.39.0
EPS
EPS
5.75.06.35.79.717.411.49.78.67.89.08.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
133126162222165148320375378557711722
Growth
Revenue Growth%
11.2-5.228.137.0-25.7-10.3116.517.10.847.327.713.3
Expenses
ExpensesCr
125113142170139115245300307428599611
Operating Profit
Operating ProfitCr
81420522633757571129112112
OPM
OPM%
6.211.012.623.415.722.123.519.918.723.115.815.5
Other Income
Other IncomeCr
410111387322
Interest Expense
Interest ExpenseCr
776311111344
Depreciation
DepreciationCr
555858667101718
PBT
PBTCr
03104222257275701199392
Tax
TaxCr
000658191918312324
PAT
PATCr
0310361717535652887068
Growth
PAT Growth%
107.6720.6193.9271.6-52.82.9204.95.3-6.568.0-20.4-29.7
NPM
NPM%
0.32.66.016.210.311.816.615.013.915.89.99.4
EPS
EPS
0.21.64.818.08.58.826.728.126.344.235.233.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
133126162222165148320375378557711722
Growth
Revenue Growth%
11.2-5.228.137.0-25.7-10.3116.517.10.847.327.713.3
Expenses
ExpensesCr
125113142170139115245300307428599611
Operating Profit
Operating ProfitCr
81420522633757571129112112
OPM
OPM%
6.211.012.623.415.722.123.519.918.723.115.815.5
Other Income
Other IncomeCr
410111387322
Interest Expense
Interest ExpenseCr
776311111344
Depreciation
DepreciationCr
555858667101718
PBT
PBTCr
03104222257275701199392
Tax
TaxCr
000658191918312324
PAT
PATCr
0310361717535652887068
Growth
PAT Growth%
107.6720.6193.9271.6-52.82.9204.95.3-6.568.0-20.4-29.7
NPM
NPM%
0.32.66.016.210.311.816.615.013.915.89.99.4
EPS
EPS
0.21.64.818.08.58.826.728.126.344.235.233.9

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
-10-73385573124174220302363
Current Liabilities
Current LiabilitiesCr
856766481933456366108146
Non Current Liabilities
Non Current LiabilitiesCr
177125444579
Total Liabilities
Total LiabilitiesCr
91778610789120182252301426528
Current Assets
Current AssetsCr
403042704875128189201246259
Non Current Assets
Non Current AssetsCr
5147433741455463100180269
Total Assets
Total AssetsCr
91778610789120182252301426528
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
-10-73385573124174220302363
Current Liabilities
Current LiabilitiesCr
856766481933456366108146
Non Current Liabilities
Non Current LiabilitiesCr
177125444579
Total Liabilities
Total LiabilitiesCr
91778610789120182252301426528
Current Assets
Current AssetsCr
403042704875128189201246259
Non Current Assets
Non Current AssetsCr
5147433741455463100180269
Total Assets
Total AssetsCr
91778610789120182252301426528

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1616173722374443343343
Investing Cash Flow
Investing Cash FlowCr
-1-1-1-3-9-34-35-40-30-42-91
Financing Cash Flow
Financing Cash FlowCr
-15-15-17-34-12-1-5-6-73238
Net Cash Flow
Net Cash FlowCr
0000025-3-323-9
Free Cash Flow
Free Cash FlowCr
1515173511292928-2-64-39
CFO To PAT
CFO To PAT%
3,998.4483.2179.6102.6128.5212.982.576.565.237.361.9
CFO To EBITDA
CFO To EBITDA%
195.8114.785.371.384.1113.858.557.448.425.538.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1616173722374443343343
Investing Cash Flow
Investing Cash FlowCr
-1-1-1-3-9-34-35-40-30-42-91
Financing Cash Flow
Financing Cash FlowCr
-15-15-17-34-12-1-5-6-73238
Net Cash Flow
Net Cash FlowCr
0000025-3-323-9
Free Cash Flow
Free Cash FlowCr
1515173511292928-2-64-39
CFO To PAT
CFO To PAT%
3,998.4483.2179.6102.6128.5212.982.576.565.237.361.9
CFO To EBITDA
CFO To EBITDA%
195.8114.785.371.384.1113.858.557.448.425.538.7

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2561113217792445809951,9622,8913,7387,411
Price To Earnings
Price To Earnings
62.918.611.76.04.713.910.917.737.432.826.6101.1
Price To Sales
Price To Sales
0.20.50.71.00.51.61.82.65.25.25.310.3
Price To Book
Price To Book
419.218.99.04.51.22.94.35.48.59.35.010.3
EV To EBITDA
EV To EBITDA
9.98.37.74.43.17.37.513.127.622.533.967.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.026.526.433.830.335.332.329.130.133.026.026.0
OPM
OPM%
6.211.012.623.415.722.123.519.918.723.115.815.5
NPM
NPM%
0.32.66.016.210.311.816.615.013.915.89.99.4
ROCE
ROCE%
13.417.328.174.734.330.754.641.430.734.320.820.8
ROE
ROE%
721.8101.276.674.926.021.039.930.522.828.318.818.8
ROA
ROA%
0.44.311.333.519.114.529.222.317.420.713.313.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2561113217792445809951,9622,8913,7387,411
Price To Earnings
Price To Earnings
62.918.611.76.04.713.910.917.737.432.826.6101.1
Price To Sales
Price To Sales
0.20.50.71.00.51.61.82.65.25.25.310.3
Price To Book
Price To Book
419.218.99.04.51.22.94.35.48.59.35.010.3
EV To EBITDA
EV To EBITDA
9.98.37.74.43.17.37.513.127.622.533.967.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
18.026.526.433.830.335.332.329.130.133.026.026.0
OPM
OPM%
6.211.012.623.415.722.123.519.918.723.115.815.5
NPM
NPM%
0.32.66.016.210.311.816.615.013.915.89.99.4
ROCE
ROCE%
13.417.328.174.734.330.754.641.430.734.320.820.8
ROE
ROE%
721.8101.276.674.926.021.039.930.522.828.318.818.8
ROA
ROA%
0.44.311.333.519.114.529.222.317.420.713.313.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Tanfac Industries is one of India’s largest makers of hydrofluoric acid (HF)-the corrosive, hard-to-handle building block of all fluorine chemistry-operating from a single 60-acre site in Cuddalore, Tamil Nadu, since 1985. Originally a joint venture between the Aditya Birla Group and the Tamil Nadu government’s industrial arm, the company was reshaped in 2022 when specialty-chemical firm Anupam Rasayan acquired the Birla stake and took joint control, bringing new technical depth and a deliberate push downstream. The recurring idea that explains Tanfac is a step-by-step climb from making a dangerous commodity acid to using it captively in higher-value products-first solar-grade chemicals, next refrigerant gases-so that each new stage is fed by the one beneath it. # Business segments A single integrated platform with four layers of value addition-a commodity acid backbone, a high-purity solar-chemical business, a portfolio of specialty fluoride salts, and a refrigerant-gas plant under construction-each layer consuming the output of the one before. ## 1. Hydrofluoric Acid and Sulphuric Acid: the captive feedstock engine **The company makes its own sulphuric acid from molten sulphur, then uses that acid to produce hydrofluoric acid-so the two core raw materials are under one roof, and the surplus HF is sold to external customers while the rest feeds every downstream product.** - **Backward-integrated to sulphur** - Sulphur is converted into sulphuric acid in a 100,000-tonne-per-year plant that ran at 101% utilisation in FY26; that acid is then used captively to make HF, creating a chain from elemental sulphur all the way to finished fluorochemicals. - **One of India’s largest HF plants** - The HF capacity was doubled to 29,700 tonnes per year via a brownfield expansion commissioned in October 2024, completed in 17 months at what management calls the lowest per-tonne investment in the industry, making the Cuddalore site among the biggest HF plants in the country. - **The commodity anchor** - HF alone contributed 85% of revenues in FY26, and the company intends to channel the majority of its expanded output into high-end specialty fluoride molecules within its group. - **Safety as a barrier** - Handling hydrofluoric acid, sulphuric acid and oleum requires dedicated storage, double-armoured transfer lines, remote-operated valves and online respiratory systems; the company’s four-decade safety record and certifications make it hard for new entrants to replicate. - **Raw-material sourcing derisked** - Fluorspar and potassium carbonate are imported, and the company has widened its vendor base from a historic dependence on China to include South Africa, Thailand and Vietnam, while molten sulphur comes from a long-term tie-up with the nearby Chennai Petroleum refinery. ## 2. Solar Grade Diluted Hydrofluoric Acid: the high-purity first-mover bet **Tanfac is the first and only Indian manufacturer of solar-grade DHF, used to etch silicon wafers into solar cells, and has already locked in orders worth about ₹1,068 crore before its second production line was even commissioned.** - **First to market in India** - The company commissioned its first 5,000-tonne high-purity solar-grade DHF plant in June 2025 and doubled total capacity to 20,000 tonnes per year by October 2025, with a further expansion to 40,000 tonnes now proposed. - **Orders secured before full build-out** - Two long-term supply contracts-one with Kredence Electronics Materials for ₹732 crore and another with Krishna Organics for ₹336 crore-cover offtake through FY29, requiring no additional capex to fulfil. - **Feeds the solar and semiconductor supply chain** - Solar-grade DHF is used for cleaning and etching silicon wafers in photovoltaic cell manufacturing, and the company is already pursuing the next purity tier, electronic-grade DHF, for semiconductor applications. ## 3. Specialty Fluorides: the diversified derivatives portfolio **A range of fluoride salts and complexes-potassium fluoride, potassium bifluoride, boron trifluoride complex and others-serves pharmaceuticals, agrochemicals and advanced materials, with R&D now pointed at next-generation fluoropolymers and battery chemicals.** - **Twelve-plus niche variants** - The portfolio spans fluorinating agents for organic synthesis, electrolytes for fluorine cells, Lewis acid catalysts, and fluxes for aluminium smelters, produced in a plant with \~135,000 MTPA manufacturing capacity. - **Synergy with the parent** - Anupam Rasayan is one of India’s largest users of potassium fluoride, and the acquisition gave it confidence to develop hydrogen-fluoride-based products for agrochemicals, pharmaceuticals and polymers using Tanfac’s output. - **R&D as the growth engine** - The Cuddalore lab houses expertise in vapour-phase fluorination, Halex reactions and side-chain fluorination, and has a pilot plant for refrigerants and monomers; the pipeline now targets electronic-grade chemicals, battery materials and high-performance fluoropolymers. ## 4. HFC-32 Refrigerant Gas: the downstream plant under construction **A ₹495-crore, 20,000-tonne-per-year HFC-32 plant is being built at the same Cuddalore site, with nearly two-thirds of its capacity already contracted to Japanese, multinational and Indian buyers before commissioning, which is targeted for Q3 FY27.** - **Forward integration from captive HF** - The plant extends the value chain from sulphur to sulphuric acid to HF and finally to HFC-32 refrigerant gas, giving Tanfac a cost edge through in-house feedstock. - **Demand riding India’s air-conditioner boom** - Domestic HFC-32 consumption of roughly 22,000-23,000 tonnes is expected to nearly double in four to five years as the room-AC market grows at 16-17% annually. - **Long-term contracts de-risk the ramp-up** - A seven-year deal with a Japanese customer covers 7,500 tonnes per year (₹337.5 crore annually), a five-year MoU with a multinational covers 5,000 tonnes (₹250 crore annually), and an indefinite agreement with Blue Star adds another ₹61 crore per year-together aggregating about ₹3,612 crore over five to seven years. - **Technology and export reach** - Process know-how comes from Buss Chemtech (Switzerland) and Chenco (Germany), with a separate Japanese partner for the refrigerant-gas tie-up; target export markets include Japan, the Middle East, Africa and Europe. # Group structure and partners **Tanfac is a joint-sector enterprise controlled equally by Anupam Rasayan India and the Tamil Nadu government’s TIDCO, with Anupam Rasayan driving day-to-day operations and technology while TIDCO provides institutional ballast.** - **Ownership reset in 2022** - Anupam Rasayan acquired the Aditya Birla Group’s 24.96% stake for ₹148 crore and completed a mandatory open offer, stepping into all rights under the original 1980 joint-venture agreement and becoming a co-promoter alongside TIDCO. - **Governance split** - So long as TIDCO holds 26% and Anupam Rasayan holds 25%, both have equal board seats; TIDCO appoints the chairman (with a casting vote), Anupam Rasayan appoints the managing director, and day-to-day management rests with the MD under board supervision. - **TIDCO’s put option** - The amended joint-venture agreement grants TIDCO the right to require Anupam Rasayan to buy its entire 26.02% stake at a price determined by the highest of seven specified formulae. - **No subsidiaries** - Tanfac has no subsidiaries, joint ventures or associate companies, and its shares are listed solely on BSE.

Documents — Tanfac Industries Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/apbfy8g53revuezhfoep1yzt.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/s3dbw87fdvvyg3327kcnlkay.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/1anmqbdq2ktcm1222zqjvilx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/fod151wc0kenbe5v6rnhnecd.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/poszvyj7c7fltqom3avszneg.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/h6hu89242lmoouul8d77jnip.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/8pjmay0w1al94s5ceoyeb25n.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/026yw2sc37hk59buvmrgt2ro.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/4bhh59rwolhlytwgrerumpvb.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/ndavczj4ks3g171kghk0l5nw.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/qawplj5t2pebmqex23y8d94a.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/aomqifmwubqqdcs5mun5hvbu.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/rjfioa3ixo9n4e5j3g6moxos.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/0o43uw4q1asspbw1lhyc9d59.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/2dt96mylnstzadysnp7o1shs.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/8y6c8nxlg512u93emynotlva.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/0earx2ygs9hlvr849hj0sdao.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/m7z2qikje44yw4aoxa0s913y.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/g0iu5v88rwnb7tsacr6t24it.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/jpci31u3aflupaaaqk9zpfe6.pdf

Concall Transcript Summaries — Tanfac Industries Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/BSE%3ATANFACIND/transcript-notes/202606/apbfy8g53revuezhfoep1yzt.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/BSE%3ATANFACIND/transcript-notes/202603/s3dbw87fdvvyg3327kcnlkay.pdf